Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanfang Guan

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
JCO Precision Oncology|September 14, 2020
Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant ChemotherapyShunying Li, Hongna Lai, Jieqiong Liu, et al.
Immunotherapy|March 24, 2022
Safety and efficacy of mutant neoantigen-specific T-cell treatment combined anti-PD-1 therapy in stage IV solid tumorsQi Song, Bo Yang, Wei Sheng, et al.
Briefings in Bioinformatics|December 31, 2024
Precise identification of somatic and germline variants in the absence of matched normal samplesHui Li, Lu Meng, Hongke Wang, et al.
Molecular Cancer Therapeutics|April 25, 2019
Genotyping of Circulating Tumor DNA Reveals the Clinically Actionable Mutation Landscape of Advanced Colorectal CancerWeiguo Cao, Yaping Xu, Lianpeng Chang, et al.
British Journal of Cancer|October 17, 2022
Utility of cell-free DNA from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodulesXinyu Zhang, Zhuo Yu, Yaping Xu, et al.
Cell Death & Disease|May 13, 2020
Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancerJian Yang, Yuhua Gong, Vincent K Lam, et al.
BMC Cancer|July 21, 2023
SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapyXiaobin Zheng, Jing Lin, Jiani Xiong, et al.
Medcomm|December 5, 2025
Personalized and Tumor Informed Circulating Tumor DNA Assay for Molecular Residual Disease Monitoring of Solid MalignanciesLiping Liu, WenHua Liang, WuQiang Cao, et al.
Ebiomedicine|January 16, 2025
Circulating tumour DNA in predicting and monitoring survival of patients with locally advanced rectal cancer undergoing multimodal treatment: long-term results from a prospective multicenter studyJiaolin Zhou, Lifeng Li, Yuxin Liu, et al.
Oncogene|April 26, 2022
Genomic and TCR profiling data reveal the distinct molecular traits in epithelial ovarian cancer histotypesShan Zhu, Chunliu Zhang, Dongyan Cao, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
JCO Precision Oncology|September 14, 2020
Circulating Tumor DNA Predicts the Response and Prognosis in Patients With Early Breast Cancer Receiving Neoadjuvant ChemotherapyShunying Li, Hongna Lai, Jieqiong Liu, et al.
Immunotherapy|March 24, 2022
Safety and efficacy of mutant neoantigen-specific T-cell treatment combined anti-PD-1 therapy in stage IV solid tumorsQi Song, Bo Yang, Wei Sheng, et al.
Briefings in Bioinformatics|December 31, 2024
Precise identification of somatic and germline variants in the absence of matched normal samplesHui Li, Lu Meng, Hongke Wang, et al.
Molecular Cancer Therapeutics|April 25, 2019
Genotyping of Circulating Tumor DNA Reveals the Clinically Actionable Mutation Landscape of Advanced Colorectal CancerWeiguo Cao, Yaping Xu, Lianpeng Chang, et al.
British Journal of Cancer|October 17, 2022
Utility of cell-free DNA from bronchial washing fluid in diagnosis and genomic determination for radiology-suspected pulmonary nodulesXinyu Zhang, Zhuo Yu, Yaping Xu, et al.
Cell Death & Disease|May 13, 2020
Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancerJian Yang, Yuhua Gong, Vincent K Lam, et al.
BMC Cancer|July 21, 2023
SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapyXiaobin Zheng, Jing Lin, Jiani Xiong, et al.
Medcomm|December 5, 2025
Personalized and Tumor Informed Circulating Tumor DNA Assay for Molecular Residual Disease Monitoring of Solid MalignanciesLiping Liu, WenHua Liang, WuQiang Cao, et al.
Ebiomedicine|January 16, 2025
Circulating tumour DNA in predicting and monitoring survival of patients with locally advanced rectal cancer undergoing multimodal treatment: long-term results from a prospective multicenter studyJiaolin Zhou, Lifeng Li, Yuxin Liu, et al.
Oncogene|April 26, 2022
Genomic and TCR profiling data reveal the distinct molecular traits in epithelial ovarian cancer histotypesShan Zhu, Chunliu Zhang, Dongyan Cao, et al.
Pageof 13